To elaborate on what the networking kingpin could have to offer for 2015, Cramer spoke with Cisco Systems CEO John Chambers.
The company recently shifted its focus toward delivering more software and cloud-based solutions. However, more software could also mean more cybersecurity risk. Where does Chambers see the future of cybersecurity in the next five years?
"Security is a must. You and I talked about how there is no such thing as a secure environment a year or two ago, and that has turned out to be very true…I think the market is still way too conservative on the loads on networks and the amount of information," Chambers said.
Additionally, Chambers commented regarding the pending litigation with Arista Networks. Cisco filed patent and copyright infringement charges against the startup, which is headed by former Cisco employee Jayshree Ullal.
"I don't think anything personal on this, I just think about every decade we have to remind our peers that we do invest in our future innovation and we will hold people accountable not to copy that."
One stock that rallied in Monday's session was Isis Pharmaceuticals. This stock climbed 10.72 percent after it announced a major partnership with Johnson & Johnson to develop antisense drugs for autoimmune disorders that affect the gastrointestinal tract.
With 34 different development programs in its pipeline and now this partnership with JNJ, it's not hard to see why this is a Cramer fave stock.
To get the scoop, Cramer spoke with Isis Pharmaceuticals CEO Dr. Stanley Crooke. The CEO elaborated on the partnership, and explained that it will expand the innovation of technology because the treatment is focused on oral administration for local treatment of gastrointestinal diseases.
"That is a space that is new for technology but is adjacent to areas we have worked before, so we have high confidence it can work and expand the breadth of the utility of technology. I think that's the thing that should get people the most excited. It's one more notch on the belt of all of the opportunities that we have to take advantage of," Chambers said
Cramer continued to search for the winners of Monday's downslide when he gave his take on a few caller favorites in the Lightning Round:
Sprint: "I think now you just have to hold it. It would have been great at $6,$7 or $5, but not here. It's too low. I do think it can go to $3.50, but that's being too clever by half."
Sierra Wireless: "A good company, but right now I prefer for you to go with a combination of Cypress and Spansion, which has a lot more room to grow."
Read MoreLightning Round: The scoop on Apple